Scleritis is a painful and potentially serious eye condition that affects the white of the eye (sclera). It is an inflammation of the sclera, the tough, outer layer of the eyeball. It can be caused by a variety of factors, including autoimmune disorders, infection, and trauma. It is important to identify the underlying cause of scleritis to determine the best treatment plan. This article will provide an overview of the causes and treatments of scleritis, as well as tips for prevention.
Scleritis is an inflammation of the sclera, the tough, outer layer of the eyeball. It is a rare condition, affecting about 1 in 10,000 people. It can affect one or both eyes, and can occur at any age. Scleritis can range from mild to severe, and can cause pain, redness, and swelling of the affected eye or eyes. It can also cause light sensitivity, blurred vision, and vision loss.
The exact cause of scleritis is not known, but it is often associated with an underlying autoimmune disorder, such as rheumatoid arthritis, lupus, or Sjogren's syndrome. It can also be caused by infection, such as herpes simplex virus, or trauma, such as a blunt force injury. In some cases, the cause of scleritis is unknown.
The treatment for scleritis depends on the underlying cause. If the cause is an autoimmune disorder, the goal of treatment is to reduce inflammation and control the underlying disorder. This may involve medications, such as non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, or immunosuppressants. If the cause is an infection, antibiotics may be prescribed. If the cause is trauma, the treatment may involve rest and pain relief. In some cases, surgery may be necessary to repair the affected area.
There are several steps that can be taken to reduce the risk of scleritis. These include avoiding eye injuries, wearing protective eyewear, and avoiding contact with people who have an infection. It is also important to treat any underlying autoimmune disorders, as this can help reduce the risk of scleritis.
Scleritis is a painful and potentially serious eye condition that can cause pain, redness, and vision loss. It is important to identify the underlying cause of scleritis to determine the best treatment plan. Treatment may involve medications, such as NSAIDs, corticosteroids, or immunosuppressants. Surgery may also be necessary in some cases. There are steps that can be taken to reduce the risk of scleritis, such as avoiding eye injuries, wearing protective eyewear, and avoiding contact with people who have an infection.
1.
Breast Cancer Patients Living Longer Post-Medicaid Expansion
2.
Error on the MGUS-Autoimmune Disease Association.
3.
Patients with chronic myeloid leukemia who take nilotinib are at higher risk for diabetes and hyperlipidemia.
4.
The majority of cancer medications that receive expedited approval end up failing confirmatory trials.
5.
Unified Neuro/Psych Residency Program: New Proposal.
1.
Optimizing Melanoma Treatment: Strategies in Diagnosis, Clinical Research, and Physician Training
2.
Hemoglobin C: Understanding its Role in Sickle Cell Disease
3.
Beyond the Human Eye: How AI Is Redefining Brain Cancer Diagnosis Through Advanced Imaging
4.
Understanding Abemaciclib: A Breakthrough Treatment for Breast Cancer
5.
The Growing Challenge of Haematological Malignancies in Older Adults
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II
2.
Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial
3.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII
4.
A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC
5.
Efficient Management of First line ALK-rearranged NSCLC - Part VI
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation